Cormedix Inc (CRMD) 7.75 $CRMD CorMedix Announces

New Post Public Reply Private Reply Replies (0) Message Board

Mar 21, 2015 at 11:57 PM

Cormedix Inc (CRMD) 7.75 $CRMD

CorMedix Announces Effectiveness of Registration Statements for Shares Underlying Publicly Traded Warrants
PR Newswire - Fri Mar 20, 7:00AM CDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced that the registration statements for the shares of its common stock underlying its publicly traded warrants with CUSIP number (No.21900C118) have both been declared effective by the Securities and Exchange Commission. Holders of publicly traded warrants who wish to exercise their warrants will receive freely tradable shares of common stock upon presentation of a properly completed exercise notice and full payment for exercise. As previously reported, the expiration date for these publicly traded warrants is April 30, 2015.
CRMD: 7.75 (-0.18)

CorMedix (CRMD) Looks Good: Stock Moves 8.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 18, 8:25AM CDT
CorMedix (CRMD) was a big mover last session, with shares rising roughly 9% on the day.
CRMD: 7.75 (-0.18), AFFX: 12.87 (-0.07)

Borrow Costs Elevated On CorMedix
Interactive Brokers - at Seeking Alpha - Tue Mar 17, 2:09AM CDT
CorMedix, Inc. (NYSEMKT: CRMD ) continues to be a difficult borrow as demand has far exceeded the lendable supply. Over the past two weeks the amount of shares traded in the cash market has been well above historical averages while the amount of...
CRMD: 7.75 (-0.18), EYES: 13.67 (+0.11), SHAK: 46.92 (-0.65), MELA: 3.16 (-0.16), GME: 40.92 (+0.13), AMRN: 2.52 (-0.03), AXN: 1.72 (-0.15), FXCM: 2.10 (+0.04), WBAI: 11.06 (+1.08), RESN: 9.72 (-0.15), WPRT: 4.15 (+0.02), RIG: 14.99 (+0.83), CYTX: 1.19 (-0.03), CEN: 17.60 (-0.05), CAPN: 5.37 (-0.33)

CorMedix's (CRMD) CEO Randy Milby on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Mar 13, 4:36PM CDT

CRMD: 7.75 (-0.18)

Seeking Alpha's Biotech Weekly: Deeper Looks At Orexigen, Pharmacyclics, And Acadia
SA Editor Mike Taylor - Seeking Alpha - Fri Mar 13, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
ACT: 317.06 (+2.65), PCYC: 257.85 (-0.21), ITEK: 5.75 (-0.19), REDX: (), PTX: 10.40 (-0.34), CLDX: 30.38 (-1.40), ILMN: 196.02 (-3.79), IDGX: (), ACAD: 34.45 (-0.54), TRGT: 2.66 (-0.07), CLLS: (), EXAC: 25.30 (+0.52), ABBV: 60.40 (-0.79), CRMD: 7.75 (-0.18), AGMX: (), ZGNX: 1.38 (+0.02), VVUS: 2.97 (-0.02), SPPI: 6.17 (-0.24), GSK: 48.81 (+0.60), OREX: 7.19 (-0.41), SQNM: 3.91 (-0.03), IRWD: 16.59 (+0.18), GILD: 102.29 (+0.85), MRK: 58.58 (+0.37), OHRP: 9.26 (-0.09), TEVA: 62.10 (+0.55)

CorMedix reports FY14 results
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 7:48AM CDT

CRMD: 7.75 (-0.18)

CorMedix: Up Too Far Too Fast
Amit Ghate - at Seeking Alpha - Tue Mar 10, 7:46AM CDT

CRMD: 7.75 (-0.18)

CorMedix Clarifies Extension of Expiration Date for Publicly Traded Warrants
PR Newswire - Mon Mar 09, 8:00AM CDT
CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases, today announced that the extension to April 30, 2015 of the expiration date applies to all publicly traded warrants.
CRMD: 7.75 (-0.18)

CorMedix (CRMD) Surges: Stock Adds 26% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 06, 8:25AM CST
CorMedix (CRMD) was a big mover last session, with shares surging almost 26% on the day.
CRMD: 7.75 (-0.18), AFFX: 12.87 (-0.07)

Next Week In Biotech: Kythera Ad Comm, Roth Conference, Zogenix Earnings
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BDSI: 14.97 (-0.25), OMED: 28.00 (+0.92), BIOA: 9.00 (+0.03), SUPN: 11.35 (-0.11), CTIC: 1.93 (unch), ALXA: 2.13 (-0.04), DSCI: 8.86 (-0.11), ANTH: 4.34 (-0.08), CYTX: 1.19 (-0.03), KYTH: 48.22 (+0.21), ANAC: 54.24 (-1.88), ATHX: 3.20 (+0.03), CRMD: 7.75 (-0.18), ACRX: 4.15 (-0.09), TROV: 7.04 (-0.35), ZGNX: 1.38 (+0.02), PETX: 18.74 (-0.30), RPRX: 8.98 (-0.26), IMUC: 0.57 (-0.01), PGNX: 6.06 (-0.45), SNTA: 2.48 (+0.07), BLCM: 25.19 (-0.71), TXMD: 6.40 (+0.15), OGXI: 2.30 (-0.16), AST: 7.88 (-0.40), PLX: 1.76 (-0.03), ATRS: 2.67 (-0.02)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 11:45AM CST

CRMD: 7.75 (-0.18), EYES: 13.67 (+0.11), ECR: 6.04 (-0.07), CECE: 12.06 (-0.05), DRAM: 2.30 (+0.09), NVGN: 3.82 (-0.14), AMED: 26.74 (-0.25), VSLR: 12.93 (-0.20), MOMO: 10.41 (+0.39), GEF: 38.69 (-1.09), RNDY: 4.79 (-0.04), SMTC: 28.47 (+0.24), EVOK: 7.00 (-0.22), KYTH: 48.22 (+0.21), GERN: 3.98 (-0.15), LTRE: 1.62 (+0.16), ENRJ: 1.61 (+0.15), PEIX: 10.77 (+0.27), ALG: 60.58 (+1.38), CAPN: 5.37 (-0.33)

Cormedix closes $4.5M backstop financing
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 10:32AM CST

CRMD: 7.75 (-0.18)

Premarket Gainers / Losers as of 9:10 em
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 8:13AM CST

BV: 5.90 (+0.01), AMRN: 2.52 (-0.03), PHMD: 1.79 (+0.04), BOBE: 46.64 (+0.28), NVGN: 3.82 (-0.14), EFUT: 3.98 (-0.08), TNET: 36.25 (+0.28), ATOS: 1.97 (+0.01), FAST: 42.30 (-0.17), W: 31.94 (-1.13), TIVO: 10.61 (+0.02), CYCC: 0.98 (+0.02), ANF: 21.87 (+0.53), CYTX: 1.19 (-0.03), AEO: 17.07 (+0.02), AMBA: 72.39 (+3.14), CRMD: 7.75 (-0.18), ONCY: 0.81 (-0.02), EXAS: 24.18 (-0.20), ATHM: 44.49 (+1.94), SOL: 1.62 (+0.14), VEEV: 27.28 (-0.65), OREX: 7.19 (-0.41), NURO: 1.73 (unch), ACHN: 11.06 (-0.36), CNDO: 3.90 (-0.31), SWHC: 13.53 (+0.10), IFON: 2.30 (+0.03)

Strength Seen in CorMedix (CRMD): Stock Soars 27.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 8:25AM CST
CorMedix (CRMD) was a big mover last session, with shares rising almost 28% on the day.
CRMD: 7.75 (-0.18), AFFX: 12.87 (-0.07)

CorMedix adds to Neutrolin FT-stoked up move
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:40AM CST

CRMD: 7.75 (-0.18)

CorMedix (CRMD) Shows Strength: Stock Moves Up 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 7:51AM CST
CorMedix, Inc. (CRMD) was a big mover last session, as the company saw its shares rise almost 6% on the day.
CRMD: 7.75 (-0.18), AFFX: 12.87 (-0.07)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 4:37PM CST

CRMD: 7.75 (-0.18), TTWO: 25.68 (-0.04), MYGN: 37.03 (-0.13), BC: 51.25 (+0.15), CMG: 686.65 (+5.98), MXL: 8.24 (+0.05), WTW: 8.60 (-0.81), DWTI: 149.45 (-10.55), PLNR: 6.16 (-0.11), ENTR: 3.00 (+0.02)

CorMedix up on QIDP designation
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 9:37AM CST

CRMD: 7.75 (-0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

HONA Faces Legal Heat: Investor Lawsuit Over Losses

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

AI and Storytelling Make Waves in Science Education

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

CVS Health Under Fire: Fiduciary Duty Breach?

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

PACS Group Faces Legal Scrutiny: What to Watch

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Quay Sunglasses: Luxury Looks, Affordable Prices

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Jackson Wang's Fantasy IP Hits Hong Kong Stage

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Geron Corp Faces Fiduciary Duty Investigation

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...